After taking Monday off, the Department of Defense's acquisitions specialists got back to work today, awarding 18 separate defense contracts Tuesday, worth a total of $4.22 billion.
Foreign-listed companies made out particularly well in this latest round of contract awards, with contracts being awarded to:
- Hikma Pharmaceuticals (HIK -0.33%) subsidiary West-Ward Pharmaceuticals, which was awarded the first of nine possible one-year long "option" exercises on a contract to supply "various pharmaceutical products" to the U.S. Army, Navy, Air Force, and Marine Corps. This option exercise will be worth up to $70.9 million to Hikma and will run through at least Feb. 26, 2015.
- Bayer AG (BAYR.Y 0.44%) subsidiary Bayer Healthcare Pharmaceuticals, which won a similar option-year extension (the second of seven possible) on a contract to supply "various pharmaceutical products" to the U.S. Army, Navy, Air Force, Marine Corps, and federal civilian agencies. The value of Bayer's option is put at up to $49.4 million, and its contract will now run through at least March 5, 2015.
- DRS Tactical Systems, a subsidiary of Italy's Finmeccanica (FINMY -0.85%), which won a $12.6 million firm-fixed-price contract to supply the U.S. Army with improved platform integration kits for M777A2 115mm and M119A3 105mm howitzers. Deliver is due Feb. 27, 2019.